Prosecution Insights
Last updated: May 29, 2026
Application No. 18/036,979

THERMOSETTING RESIN COMPOSITION, CURED PRODUCT, AND PRINTED WIRING BOARD

Final Rejection §102§103§112
Filed
May 15, 2023
Priority
Nov 17, 2020 — JP 2020-191176 +1 more
Examiner
CAI, WENWEN
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Taiyo Holdings Co. Ltd.
OA Round
2 (Final)
60%
Grant Probability
Moderate
3-4
OA Rounds
1m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allowance Rate
514 granted / 858 resolved
-5.1% vs TC avg
Strong +20% interview lift
Without
With
+20.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
52 currently pending
Career history
928
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
73.2%
+33.2% vs TC avg
§102
7.2%
-32.8% vs TC avg
§112
8.2%
-31.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 858 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claim s1, 3-9 in the reply filed on 12/8/2025 is acknowledged. Claims 2, 10-12 withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 12/8/2025. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (B) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 8 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. Claim 8 recites “the storage elastic modulus of the cured product obtained by curing the thermosetting resin composition at 20°C is …”. The claim limitation has no patentable weight and is meaningless from a scientific point of view because 1) it is unclear if 20°C is the curing temperature or modulus measuring temperature, 2) it does not recite for how long the composition is cured, by adjusting the curing time, the claimed modulus can always be achieved, 3) modulus measuring frequency, strain amplitude and temperature are not recited. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 4-9 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Luo et al (US 2020/0325346). Claims 1, 4, 6-7: Luo teaches a composition comprising 16wt% of a hydroxy group-containing fluororesin, 9wt% of a blocked isophorone polyisocyanate Vestagon B 1530, and 29wt% of rutile titanium oxide Ti-Pure R960 [0137-0143]. The fluororesin is a copolymer of a fluorine containing vinyl monomer CTFE and a hydroxy group containing vinyl monomer HBVE 4-hydroxybutyl vinyl ether. Claim 5: the fluorine containing vinyl monomer can be tetrafluoroethylene, CTFE, etc [0078]. Claim 8: because Luo teaches the claimed composition, it is therefore inherent that the composition exhibit claimed property since such a property is evidently dependent upon the nature of the composition used, see MPEP 2112.01. Absent an objective showing to the contrary, the addition of the claimed physical properties to the claim language fails to provide patentable distinction over the prior art. Claim 9: The composition can be used as claimed. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1, 3 is/are rejected under 35 U.S.C. 103 as being unpatentable over Luo et al (US 2020/0325346). Luo teaches a composition comprising 10-50 wt% of a hydroxy group-containing fluororesin, 3-30wt% of a blocked polyisocyanate Vestagon B 1530, and rutile titanium oxide Ti-Pure R960 [0115, 0118, 0120, 0137-0143]. The content of titanium oxide is 20-200 parts by mass based on the 100 parts by mass of the fluororesin [0123]. Case law holds that in the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Any inquiry concerning this communication or earlier communications from the examiner should be directed to WENWEN CAI whose telephone number is (571)270-3590. The examiner can normally be reached on M-F 9am-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on (571)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WENWEN CAI/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

May 15, 2023
Application Filed
Mar 10, 2026
Non-Final Rejection mailed — §102, §103, §112
May 07, 2026
Response Filed
May 26, 2026
Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12630685
MXENE ENHANCED URETHANE FOAM
3y 6m to grant Granted May 19, 2026
Patent 12617941
HEAT-CURABLE RESIN COMPOSITION
2y 12m to grant Granted May 05, 2026
Patent 12611650
ELECTRET AND FILTER USING THE SAME
4y 2m to grant Granted Apr 28, 2026
Patent 12606649
PROCESS FOR PREPARATION OF POLYISOBUTENE DERIVATIVES
2y 11m to grant Granted Apr 21, 2026
Patent 12600886
RESINS FOR ADHESIVE BONDING OF FABRICS
3y 6m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
60%
Grant Probability
80%
With Interview (+20.2%)
3y 2m (~1m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 858 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month